Dealing with a Mucosal Viral Pandemic: Lessons from COVID-19 Vaccines

Preclinical mucosal vaccines with intranasal or oral administration demonstrate promising results regarding mucosal IgA generation and tissue-resident lymphocyte responses against SARS-CoV-2.